Quest Partners LLC Cogent Biosciences, Inc. Transaction History
Quest Partners LLC
- $920 Billion
- Q1 2025
A detailed history of Quest Partners LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 18,750 shares of COGT stock, worth $103,875. This represents 0.01% of its overall portfolio holdings.
Number of Shares
18,750
Previous 8,012
134.02%
Holding current value
$103,875
Previous $62.5 Million
79.72%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding COGT
# of Institutions
196Shares Held
116MCall Options Held
61.9KPut Options Held
223K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$50.4 Million4.6% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY8.96MShares$49.7 Million2.75% of portfolio
-
Commodore Capital LP New York, NY8.89MShares$49.3 Million5.22% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$40.4 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$38.6 Million10.05% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $364M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...